Two Clinical Trials Using GR-MD-02 Galectin-3 Inhibitor in Combination with Cancer Immunotherapy Drugs
0 Comments , in Article
By Peter G. Traber, M.D. on November 12, 2015 The galectin-3 protein appears to play an important role in the progression of many cancers, especially with respect to the ability...
Read More